Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option

被引：21

作者：

Gontero, P ^{[1
]}

Marini, L

Frea, B

机构：

[1] Univ Piemonte Orientale, Urol Clin, Novara, Italy

[2] Eli Lilly Italy, Dept Med, Sesto Fiorentino, Italy

来源：

BJU INTERNATIONAL | 2005年 / 96卷 / 07期

关键词：

superficial bladder cancer; intravesical chemotherapy; gemcitabine; immunotherapy;

D O I：

10.1111/j.1464-410X.2005.05739.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：970 / 976

页数：7

共 50 条

[1]

BENET LZ, 1996, GOODMAN GILMAN PHARM, P4

[2] Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine) [J].

Bergman, AM ;

Pinedo, HM ;

Peters, GJ .

DRUG RESISTANCE UPDATES, 2002, 5 (01) :19-33

[3]

Böhle A, 2004, UROLOGY, V63, P682, DOI 10.1016/j.urology.2003.11.049

[4] Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer:: A formal meta-analysis of comparative studies on recurrence and toxicity [J].

Böhle, A ;

Jocham, D ;

Bock, PR .

JOURNAL OF UROLOGY, 2003, 169 (01) :90-95

[5]

Bouzid K, 2004, JCO S, V22, pA4601

[6]

Cozzi PJ, 1999, CLIN CANCER RES, V5, P2629

[7] Phase I trial of intravesical gemcitabine in bacillus Calmette-Guerin-refractory transitional-cell carcinoma of the bladder [J].

Dalbagni, G ;

Russo, P ;

Sheinfeld, J ;

Mazumdar, M ;

Tong, W ;

Rabbani, F ;

Donat, MS ;

Herr, HW ;

Sogani, P ;

dePalma, D ;

Bojorin, D .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3193-3198

[8]

DALBAGNI G, 2004, J UROLOGY, V171, pA274

[9] Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation [J].

De Berardinis, E ;

Antonini, G ;

Peters, GJ ;

Loves, WJP ;

van der Born, K ;

Codacci-Pisanelli, G ;

Di Silverio, F .

BJU INTERNATIONAL, 2004, 93 (04) :491-494

[10]

DEBERARDINIS E, 2004, J UROLOGY, V171, pA275

← 1 2 3 4 5 →